<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kiluk BD</submitter><funding>NCATS NIH HHS</funding><funding>NIAAA NIH HHS</funding><pagination>e2435205</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11428014</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(9)</volume><pubmed_abstract>&lt;h4>Importance&lt;/h4>Cognitive behavioral therapy (CBT) is an evidence-based treatment for alcohol use, yet patient access is limited and may be enhanced through digital therapeutics.&lt;h4>Objective&lt;/h4>To evaluate the efficacy of a digital CBT program (Computer-Based Training for Cognitive Behavioral Therapy [CBT4CBT]) or clinician-delivered CBT compared with standard treatment for reducing alcohol use.&lt;h4>Design, setting, and participants&lt;/h4>A 3-arm randomized clinical trial was conducted at outpatient substance use treatment facilities in Connecticut between February 14, 2017, and December 31, 2021, that included an 8-week treatment period with a 6-month follow-up period. Treatment-seeking adults were included who met criteria for current alcohol use disorder and reported drinking at least 14 (men) or 7 (women) drinks per week in the past month and were sufficiently stable for outpatient treatment.&lt;h4>Interventions&lt;/h4>Participants were randomly assigned to 1 of the following groups: (1) treatment as usual (TAU) consisting of weekly group or individual counseling, (2) CBT delivered weekly by trained and fidelity-monitored clinicians, or (3) web-based CBT plus brief weekly clinical monitoring.&lt;h4>Main outcomes and measures&lt;/h4>Rates of alcohol use were measured weekly during the treatment period and at 1-, 3-, and 6-month follow-up using the timeline follow-back method. The primary outcome was the percentage of days abstinent (PDA) from alcohol per month. Intention-to-treat analyses were conducted.&lt;h4>Results&lt;/h4>Of the 99 randomized participants (mean [SD] age, 45.5 [12.7]), 66 were male (66.7%); 39 identified as Black/African American (39.8%), 19 (19.2%) as Hispanic, and 47 (48.0%) as White. Mean (SD) rates of PDA from baseline to 6-month follow-up were 49.3% (27.8%) to 69.6% (34.4%) for TAU; 53.7% (29.8%) to 70.2% (35.1%) for CBT; and 47.6% (31.8%) to 82.6% (25.3%) for digital CBT. Results of random-effects regression showed a significant increase in PDA during the study period, with those assigned to digital CBT increasing PDA at a faster rate than TAU (t733 = 2.55; P = .01) and CBT (t733 = 3.36; P &lt; .001). However, there was no statistically significant difference between treatment groups during the 8-week treatment period.&lt;h4>Conclusions and relevance&lt;/h4>In this randomized clinical trial, while there was no significant difference between treatment groups during the 8-week treatment period, there was differential change between treatments during the 8-month study period that provides support for the efficacy of this digital CBT program.&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov Identifier: NCT02742246.</pubmed_abstract><journal>JAMA network open</journal><pubmed_title>A Digital Cognitive Behavioral Therapy Program for Adults With Alcohol Use Disorder: A Randomized Clinical Trial.</pubmed_title><pmcid>PMC11428014</pmcid><funding_grant_id>R01 AA024122</funding_grant_id><funding_grant_id>K02 AA027300</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><pubmed_authors>Nich C</pubmed_authors><pubmed_authors>Frankforter TL</pubmed_authors><pubmed_authors>LaPaglia DM</pubmed_authors><pubmed_authors>Benitez B</pubmed_authors><pubmed_authors>Kiluk BD</pubmed_authors><pubmed_authors>O'Malley SS</pubmed_authors><pubmed_authors>DeVito EE</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Digital Cognitive Behavioral Therapy Program for Adults With Alcohol Use Disorder: A Randomized Clinical Trial.</name><description>&lt;h4>Importance&lt;/h4>Cognitive behavioral therapy (CBT) is an evidence-based treatment for alcohol use, yet patient access is limited and may be enhanced through digital therapeutics.&lt;h4>Objective&lt;/h4>To evaluate the efficacy of a digital CBT program (Computer-Based Training for Cognitive Behavioral Therapy [CBT4CBT]) or clinician-delivered CBT compared with standard treatment for reducing alcohol use.&lt;h4>Design, setting, and participants&lt;/h4>A 3-arm randomized clinical trial was conducted at outpatient substance use treatment facilities in Connecticut between February 14, 2017, and December 31, 2021, that included an 8-week treatment period with a 6-month follow-up period. Treatment-seeking adults were included who met criteria for current alcohol use disorder and reported drinking at least 14 (men) or 7 (women) drinks per week in the past month and were sufficiently stable for outpatient treatment.&lt;h4>Interventions&lt;/h4>Participants were randomly assigned to 1 of the following groups: (1) treatment as usual (TAU) consisting of weekly group or individual counseling, (2) CBT delivered weekly by trained and fidelity-monitored clinicians, or (3) web-based CBT plus brief weekly clinical monitoring.&lt;h4>Main outcomes and measures&lt;/h4>Rates of alcohol use were measured weekly during the treatment period and at 1-, 3-, and 6-month follow-up using the timeline follow-back method. The primary outcome was the percentage of days abstinent (PDA) from alcohol per month. Intention-to-treat analyses were conducted.&lt;h4>Results&lt;/h4>Of the 99 randomized participants (mean [SD] age, 45.5 [12.7]), 66 were male (66.7%); 39 identified as Black/African American (39.8%), 19 (19.2%) as Hispanic, and 47 (48.0%) as White. Mean (SD) rates of PDA from baseline to 6-month follow-up were 49.3% (27.8%) to 69.6% (34.4%) for TAU; 53.7% (29.8%) to 70.2% (35.1%) for CBT; and 47.6% (31.8%) to 82.6% (25.3%) for digital CBT. Results of random-effects regression showed a significant increase in PDA during the study period, with those assigned to digital CBT increasing PDA at a faster rate than TAU (t733 = 2.55; P = .01) and CBT (t733 = 3.36; P &lt; .001). However, there was no statistically significant difference between treatment groups during the 8-week treatment period.&lt;h4>Conclusions and relevance&lt;/h4>In this randomized clinical trial, while there was no significant difference between treatment groups during the 8-week treatment period, there was differential change between treatments during the 8-month study period that provides support for the efficacy of this digital CBT program.&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov Identifier: NCT02742246.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-06-02T09:26:27.497Z</modification><creation>2025-04-06T13:22:04.625Z</creation></dates><accession>S-EPMC11428014</accession><cross_references><pubmed>39325452</pubmed><doi>10.1001/jamanetworkopen.2024.35205</doi></cross_references></HashMap>